4//SEC Filing
FRAGIN GARY S 4
Accession 0001179110-10-000197
CIK 0001107421other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 2:47 PM ET
Size
15.3 KB
Accession
0001179110-10-000197
Insider Transaction Report
Form 4
FRAGIN GARY S
Director
Transactions
- Award
Common Stock, $.001 par value
2009-12-31+7,500→ 52,500 total - Award
Stock Option (right to buy)
2009-12-31+7,500→ 7,500 totalExercise: $2.85Exp: 2019-12-31→ Common Stock, $.001 par value (7,500 underlying)
Holdings
- 15,000
Director Stock Option (right to buy)
Exercise: $5.01From: 2006-04-26Exp: 2016-04-26→ Common Stock (15,000 underlying) - 20,000
Stock Option (right to buy)
Exercise: $2.73Exp: 2017-12-12→ Common Stock (20,000 underlying) - 15,029
Director Stock Option (right to buy)
Exercise: $4.31Exp: 2014-12-22→ Common Stock, $.001 par value (15,029 underlying) - 15,000
Stock Option (right to buy)
Exercise: $4.85Exp: 2017-06-18→ Common Stock (15,000 underlying)
Footnotes (7)
- [F1]7,515 shares vest on 12/22/05 and 7,514 shares vest on 12/22/06.
- [F2]5,000 shares vest on each of 12/13/07, 12/13/08 and 12/13/09.
- [F3]5,000 shares vest on each of 6/18/08, 6/18/09 and 6/18/10.
- [F4]6,667 shares vest on each of 12/12/08 and 12/12/09; 6,666 shares vest on 12/12/10.
- [F5]5,000 shares vest on each of 12/31/2009, 6/30/2010 and 12/31/2010.
- [F6]Grant of restricted stock; restrictions lapse in 2 equal annual installments beginning on the first anniversary of the date of grant.
- [F7]3,750 shares vest on each of 12/31/2011 and 12/31/2012.
Documents
Issuer
ZIOPHARM ONCOLOGY INC
CIK 0001107421
Entity typeother
Related Parties
1- filerCIK 0001338534
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 2:47 PM ET
- Size
- 15.3 KB